maprotiline has been researched along with Uremia in 1 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lynn, K | 1 |
| Braithwaite, R | 1 |
| Dawling, S | 1 |
| Rosser, R | 1 |
1 other study available for maprotiline and Uremia
| Article | Year |
|---|---|
Comparison of the serum protein binding of maprotiline and phenytoin in uraemic patients on haemodialysis.
Topics: Adolescent; Adult; Aged; Anthracenes; Blood Proteins; Female; Humans; Male; Maprotiline; Middle Aged | 1981 |